Sho Takuma, Yuzo Suzuki, Masato Kono, Hirotsugu Hasegawa, Dai Hashimoto, Koshi Yokomura, Kazutaka Mori, Mikihiro Shimizu, Yusuke Inoue, Hideki Yasui, et al. Neutrophil-lymphocyte ratio being associated with mortality risk in patients receiving antifibrotic therapy. Respiratory medicine. 2024. 223. 107542-107542
Koichi Miyashita, Hironao Hozumi, Kazuki Furuhashi, Eiji Nakatani, Yusuke Inoue, Hideki Yasui, Yuzo Suzuki, Masato Karayama, Noriyuki Enomoto, Tomoyuki Fujisawa, et al. Impact of preexisting interstitial lung disease on mortality in COVID-19 patients from the early pandemic to the delta variant epidemic: a nationwide population-based study. Respiratory Research. 2024. 25. 1
Fumiya Nihashi, Kazuki Furuhashi, Ryo Horiguchi, Yoshihiro Kitahara, Yusuke Inoue, Hideki Yasui, Masato Karayama, Yuzo Suzuki, Hironao Hozumi, Noriyuki Enomoto, et al. CLEC10A expression defines functionally distinct subsets of conventional type 2 dendritic cells (cDC2) in the mouse lung. Allergology international : official journal of the Japanese Society of Allergology. 2024
荒井唯花, 三浦基靖, 若松しのぶ, 田中紫茉子, 田中紫茉子, 龍口万里子, 神谷千明, 安井秀樹, 佐藤亮太, 秋田敬太郎, et al. Plasma concentrations of riociguat in patients with chronic thromboembolic pulmonary hypertension treated with riociguat and balloon pulmonary angioplasty. 日本薬学会年会要旨集(Web). 2023. 143rd
宮下晃一, 穗積宏尚, 古橋一樹, 中谷英仁, 井上裕介, 安井秀樹, 鈴木勇三, 柄山正人, 榎本紀之, 藤澤朋幸, et al. COVID-19 mortality in patients with interstitial lung disease: a large-scale nationwide database study. 日本呼吸器学会誌(Web). 2023. 12
福田彩水, 三浦基靖, 山本駿, 田中紫茉子, 田中紫茉子, 袴田晃央, 袴田晃央, 中嶌八隅, 柏倉康治, 龍口万里子, et al. Population pharmacokinetics of tadalafil and ambrisentan in pediatric and adult patients with pulmonary hypertension. 日本薬剤学会年会講演要旨集(CD-ROM). 2023. 38th
